Evidence map›Paper›PMID 25845936›Full record

ArticleJournal of neurochemistry2015

Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positive.

Oliver Bogen, Olaf Bender, Jana Löwe, Wolfgang Blenau, Beatrice Thevis, Wolfgang Schröder, Richard U Margolis, Jon D Levine, Ferdinand Hucho

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Human Dorsal Root Ganglia.Frontiers in cellular neuroscience · 2019
    Review
  2. CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Oliver BogenInstitut für Chemie und Biochemie, Freie Universität Berlin, Berlin, Germany.
Olaf BenderInstitut für Chemie und Biochemie, Freie Universität Berlin, Berlin, Germany.
Jana LöweUniversität Potsdam, Institut für Biochemie und Biologie, Potsdam, Germany.
Wolfgang BlenauUniversität Potsdam, Institut für Biochemie und Biologie, Potsdam, Germany.
Beatrice ThevisDepartment of Pain Pharmacology, Grünenthal Innovation, Grünenthal GmbH, Aachen, Germany.
Wolfgang SchröderEarly Clinical Development, Department of Translational Science, Grünenthal Innovation, Grünenthal GmbH, Aachen, Germany.
Richard U MargolisDepartment of Biochemistry and Molecular Pharmacology, New York University Medical Center, New York City, New York, USA.
Jon D LevineDepartment of Medicine and Oral & Maxillofacial Surgery, University of California San Francisco, San Francisco, California, USA.
Ferdinand HuchoInstitut für Chemie und Biochemie, Freie Universität Berlin, Berlin, Germany.
Freie Universität Berlin · DEGrünenthal Group (Germany) · DEUniversity of Potsdam · DENew York University · USUniversity of California, San Francisco · US

Funding

Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor MechanismsR01AR063312 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2013 to 2022
$6.5M
Nociceptor mechanisms in the transition from acute to chronic painR01NS084545 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2014 to 2018
$3.1M
Vascular Pain MechanismsR01NS085831 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2014 to 2018
$2.3M
Mechanisms and Risk Factors in Musculoskeletal PainR01AR054635 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2007 to 2011
$1.6M
NIAMS NIH HHS AR063312NIAMS NIH HHS R01 AR054635NIAMS NIH HHS R01 AR063312NINDS NIH HHS NS084545NINDS NIH HHS NS085831NINDS NIH HHS R01 NS084545NINDS NIH HHS R01 NS085831
6 · The paper itself

Abstract

A subpopulation of nociceptors, the glial cell line-derived neurotrophic factor (GDNF)-dependent, non-peptidergic C-fibers, expresses a cell-surface glycoconjugate that can be selectively labeled with isolectin B4 (IB4 ), a homotetrameric plant lectin from Griffonia simplicifolia. We show that versican is an IB4 -binding molecule in rat dorsal root ganglion neurons. Using reverse transcriptase polymerase chain reaction (RT-PCR), in situ hybridization and immunofluorescence experiments on rat lumbar dorsal root ganglion, we provide the first demonstration that versican is produced by neurons. In addition, by probing Western blots with splice variant-specific antibodies we show that the IB4 -binding versican contains only the glycosaminoglycan alpha domain. Our data support V2 as the versican isoform that renders this subpopulation of nociceptors IB4 -positive (+). A subset of nociceptors, the GDNF-dependent non-peptidergic C-fibers can be characterized by its reactivity for isolectin B4 (IB4), a plant lectin from Griffonia simplicifolia. We have previously demonstrated that versican V2 binds IB4 in a Ca2 + -dependent manner. However, given that versican is thought to be the product of glial cells, it was questionable whether versican V2 can be accountable for the IB4-reactivity of this subset of nociceptors. The results presented here prove - for the first time - a neuronal origin of versican and suggest that versican V2 is the molecule that renders GDNF-dependent non-peptidergic C-fibers IB4-positive.

Indexed as

AnimalsGanglia, SpinalGlycoproteinsLectinsMaleNerve Fibers, UnmyelinatedNeuronsNociceptorsRatsRats, Sprague-DawleyVersicansGlycoproteinsLectinsVcan protein, ratVersicansIB4nociceptorspainsensory neuronsV2versican

Identifiers

PMID25845936
PMCPMC4472531
OpenAlexW2034440765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.